Loading...
Novo Integrated Sciences, Inc.
NVOS•NASDAQ
Healthcare
Medical - Care Facilities
$0.003
$-0.00(-15.38%)
Novo Integrated Sciences, Inc. (NVOS) Financial Performance & Income Statement Overview
Review Novo Integrated Sciences, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
5.75%
↑ 5.75%
Operating Income Growth
-17.81%
↓ 17.81%
Net Income Growth
-22.05%
↓ 22.05%
Operating Cash Flow Growth
0.00%
Operating Margin
-72.23%
↓ 72.23%
Gross Margin
40.78%
↑ 40.78%
Net Profit Margin
-207.26%
↓ 207.26%
ROE
-119.90%
↓ 119.90%
ROIC
-42.01%
↓ 42.009%
Novo Integrated Sciences, Inc. (NVOS) Income Statement & Financial Overview
Review Novo Integrated Sciences, Inc.'s (NVOS) income statement with detailed quarterly and annual figures.
| Metric | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $3.15M | $3.17M | $3.89M | $3.30M |
| Cost of Revenue | $2.25M | $1.85M | $1.95M | $2.38M |
| Gross Profit | $896893.00 | $1.32M | $1.94M | $928185.00 |
| Gross Profit Ratio | $0.28 | $0.42 | $0.50 | $0.28 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $3.42M | $2.86M | $5.26M | $4.02M |
| Operating Expenses | $3.42M | $2.86M | $5.26M | $4.02M |
| Total Costs & Expenses | $5.67M | $4.71M | $7.21M | $6.40M |
| Interest Income | $2214.00 | $2477.00 | $2219.00 | $2265.00 |
| Interest Expense | $3.08M | $1.25M | $1.22M | $490273.00 |
| Depreciation & Amortization | $556704.00 | $568209.00 | $572404.00 | $584366.00 |
| EBITDA | -$10.10M | -$924093.00 | -$2.87M | -$2.13M |
| EBITDA Ratio | -$3.20 | -$0.29 | -$0.74 | -$0.58 |
| Operating Income | -$2.52M | -$1.54M | -$3.32M | -$3.09M |
| Operating Income Ratio | -$0.80 | -$0.49 | -$0.85 | -$0.94 |
| Other Income/Expenses (Net) | -$11.22M | -$1.21M | -$1.34M | -$108277.00 |
| Income Before Tax | -$13.74M | -$2.75M | -$4.66M | -$3.20M |
| Income Before Tax Ratio | -$4.36 | -$0.87 | -$1.20 | -$0.97 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $1.06M |
| Net Income | -$13.74M | -$2.75M | -$4.68M | -$3.16M |
| Net Income Ratio | -$4.36 | -$0.87 | -$1.20 | -$0.96 |
| EPS | -$0.74 | -$0.16 | -$0.28 | -$0.20 |
| Diluted EPS | -$0.74 | -$0.16 | -$0.28 | -$0.20 |
| Weighted Avg Shares Outstanding | $18.69M | $17.64M | $16.73M | $15.76M |
| Weighted Avg Shares Outstanding (Diluted) | $18.69M | $17.64M | $16.73M | $15.76M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan